Targeting biodefense markets.
The "World Vaccine Congress 2009" held in Washington D.C. (April 20-23, 2009) sponsored several sessions focused on the vaccine market targeting biodefense. On day one of the congress, a panel discussion outlined the federal progress in medical countermeasure preparedness that included emerging infections, influenza, and biodefense focuses. The second day, a session focused on the biodefense vaccine market with both government and industry members discussing the opportunities and challenges associated with the budding market.
Olinger
Gene Garrard
GG
United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA. gene.olinger@us.army.mil
D054045:Biological Warfare Agents; D023482:Bioterrorism; D002959:Civil Defense / Q000379:methods*; D003141:Communicable Diseases / Q000276:immunology*; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D014612:Vaccines / Q000276:immunology*
D054045:Biological Warfare Agents; D014612:Vaccines